( (S (NP-SBJ (ADJP (JJ French) (JJ state-owned)) (NNP Rhone-Poulenc) (NNP S.A.)) (VP (VBZ holds) (NP (NP (CD 51) (NN %)) (PP (IN of) (NP (NNP Merieux))))) (. .)))
( (S (NP-SBJ (NNP Weatherford) (NNP International) (NNP Inc.)) (VP (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (PRP it)) (VP (VP (VBD canceled) (NP (NP (NNS plans)) (PP (IN for) (NP (DT a) (NN preferred-stock) (NN swap))))) (CC but) (VP (MD may) (VP (VB resume) (NP (NP (NN payment)) (PP (IN of) (NP (NP (NNS dividends)) (PP (IN on) (NP (DT the) (NN stock)))))))))))) (, ,) (CC and) (VP (VBD added) (SBAR (IN that) (S (NP-SBJ-1 (PRP it)) (VP (VBZ expects) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (ADVP-MNR (RB publicly)) (VB offer) (NP (QP (RB about) (CD 10) (CD million)) (JJ common) (NNS shares)))))))))) (. .)))
( (S (NP-SBJ (DT The) (NN company)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ-1 (PRP it)) (VP (VBD planned) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB offer) (NP (NP (DT an) (JJ undetermined) (NN number)) (PP (IN of) (NP (JJ common) (NNS shares)))) (PP (IN in) (NP (NP (NN exchange)) (PP (IN for) (NP (NP (DT the) (CD 585,000) (NNS shares)) (PP (IN of) (NP (NP (PRP$ its) (JJ preferred) (NN stock)) (ADJP (JJ outstanding))))))))))))))) (. .)))
( (S (NP-SBJ-1 (DT The) (NN exchange) (NN ratio)) (VP (VBD was) (ADVP-TMP (RB never)) (VP (VBN established) (NP (-NONE- *-1)))) (. .)))
( (S (NP-SBJ (NNP Weatherford)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (NN market) (NNS conditions)) (VP (VBD led) (PP-DIR (TO to) (NP (NP (DT the) (NN cancellation)) (PP (IN of) (NP (DT the) (JJ planned) (NN exchange))))))))) (. .)))
( (S (NP-SBJ (DT The) (NNS energy-services) (NN concern)) (VP (VBD said) (, ,) (ADVP (RB however)) (, ,) (SBAR (IN that) (S (PP-TMP (IN in) (NP (NNP January) (CD 1990))) (, ,) (NP-SBJ (PRP it)) (VP (MD may) (VP (VB resume) (NP (NP (NNS payments)) (PP (IN of) (NP (NP (NNS dividends)) (PP (IN on) (NP (DT the) (JJ preferred) (NN stock))))))))))) (. .)))
( (S (NP-SBJ (NNP Weatherford)) (VP (VP (VBD suspended) (NP (PRP$ its) (JJ preferred-dividend) (NN payment)) (PP-TMP (IN in) (NP (NNP October) (CD 1985)))) (CC and) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (PRP it)) (VP (VP (VBZ has) (RB n't) (NP (DT any) (NNS plans) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB catch) (PRT (RP up)) (PP (IN on) (NP (NP (NNS dividends)) (PP-LOC (IN in) (NP (NP (NNS arrears)) (NP-ADV (QP (RB about) ($ $) (CD 6) (CD million)) (-NONE- *U*))))))))))) (, ,) (CC but) (VP (MD will) (VP (VB do) (ADVP-PRD (RB so)) (NP-TMP (NP (DT some) (NN time)) (PP-TMP (IN in) (NP (DT the) (NN future))))))))))) (. .)))
( (S (ADVP (RB Additionally)) (, ,) (NP-SBJ (DT the) (NN company)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (PRP it)) (VP (VBD filed) (PP-CLR (IN with) (NP (DT the) (NNP Securities) (CC and) (NNP Exchange) (NNP Commission))) (PP (IN for) (NP (NP (DT the) (JJ proposed) (NN offering)) (PP (IN of) (NP (NP (QP (CD 10) (CD million)) (NNS shares)) (PP (IN of) (NP (JJ common) (NN stock))) (, ,) (VP (VBN expected) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN offered) (NP (-NONE- *-1)) (PP-TMP (IN in) (NP (NNP November)))))))))))))))) (. .)))
( (S (NP-SBJ (DT The) (NN company)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ-1 (NP (NP (NNP Salomon) (NNP Brothers) (NNP Inc.)) (CC and) (NP (NNP Howard) (, ,) (NNP Weil) (, ,) (NNP Labouisse) (, ,) (NNP Friedrichs) (NNP Inc.))) (, ,) (NP (NP (NNS underwriters)) (PP (IN for) (NP (DT the) (NN offering)))) (, ,)) (VP (VBD were) (VP (VBN granted) (NP (-NONE- *-1)) (NP (DT an) (NN option) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB buy) (NP (NP (RB as) (JJ much)) (PP (IN as) (NP (DT an) (JJ additional) (QP (CD 1.5) (CD million)) (NNS shares)))) (S-PRP (NP-SBJ (-NONE- *-2)) (VP (TO to) (VP (VB cover) (NP (NNS over-allotments)))))))))))))) (. .)))
( (S (NP-SBJ-1 (NNS Proceeds)) (VP (MD will) (VP (VB be) (VP (VBN used) (NP (-NONE- *-1)) (S-CLR (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB eliminate) (CC and) (VB restructure) (NP (NN bank) (NN debt)))))))) (. .)))
( (S (NP-SBJ (NNP Weatherford)) (ADVP-TMP (RB currently)) (VP (VBZ has) (NP (NP (QP (RB approximately) (CD 11.1) (CD million)) (JJ common) (NNS shares)) (ADJP (JJ outstanding)))) (. .)))
( (S (NP-SBJ-1 (NP (NNS Earnings)) (PP (IN for) (NP (NP (JJS most)) (PP (IN of) (NP (NP (DT the) (NN nation) (POS 's)) (JJ major) (JJ pharmaceutical) (NNS makers)))))) (VP (VBP are) (VP (VBN believed) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB have) (VP (VBN moved) (ADVP-DIR (RB ahead)) (ADVP-MNR (RB briskly)) (PP-TMP (IN in) (NP (DT the) (JJ third) (NN quarter))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (NP (NNS companies)) (PP (IN with) (NP (JJR newer) (, ,) (JJ big-selling) (NN prescription) (NNS drugs)))) (VP (VBD fared) (ADVP-MNR (RB especially) (RB well))))))))))) (. .)))
( (S (PP (IN For) (NP (DT the) (JJ third) (JJ consecutive) (NN quarter))) (, ,) (ADVP (RB however)) (, ,) (NP-SBJ-1 (NP (JJS most)) (PP (IN of) (NP (NP (DT the) (NNS companies) (POS ')) (NNS revenues)))) (VP (VBD were) (VP (VBN battered) (NP (-NONE- *-1)) (PP (IN by) (NP-LGS (JJ adverse) (NN foreign-currency) (NNS translations))) (PP-PRP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (DT the) (JJ strong) (NN dollar)) (ADVP-LOC (RB abroad)))))))) (. .)))
( (S (NP-SBJ (NNS Analysts)) (VP (VBD said) (SBAR (IN that) (S (NP-SBJ (NP (NNP Merck) (CC &) (NNP Co.)) (, ,) (NP (NNP Eli) (NNP Lilly) (CC &) (NNP Co.)) (, ,) (NP (NNP Warner-Lambert) (NNP Co.)) (CC and) (NP (NP (DT the) (NNP Squibb) (NNP Corp.) (NN unit)) (PP (IN of) (NP (NNP Bristol-Myers) (NNP Squibb) (NNP Co.))))) (DT all) (VP (VBD benefited) (PP-CLR (IN from) (NP (NP (JJ strong) (NNS sales)) (PP (IN of) (NP (NP (ADJP (RB relatively) (JJ new)) (, ,) (JJ higher-priced) (NNS medicines)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ (-NONE- *T*-1)) (VP (VBP provide) (NP (JJ wide) (NN profit) (NNS margins))))))))))))) (. .)))
( (S (NP-SBJ-1 (NP (ADJP (RBR Less) (JJ robust)) (NNS earnings)) (PP-LOC (IN at) (NP (NP (NNP Pfizer) (NNP Inc.)) (CC and) (NP (NNP Upjohn) (NNP Co.))))) (VP (VBD were) (VP (VBN attributed) (NP (-NONE- *-1)) (PP-CLR (TO to) (NP (NP (NP (DT those) (NNS companies) (POS ')) (JJR older) (NNS products)) (, ,) (SBAR (WHNP-2 (NP (JJ many)) (WHPP (IN of) (WHNP (WDT which)))) (S (NP-SBJ (-NONE- *T*-2)) (VP (VBP face) (NP (NP (JJ stiffening) (NN competition)) (PP (IN from) (NP (NP (JJ generic) (NNS drugs)) (CC and) (NP (JJ other) (NNS medicines)))))))))))) (. .)))
( (S (NP-SBJ (NP (NNP Joseph) (NNP Riccardo)) (, ,) (NP (NP (DT an) (NN analyst)) (PP (IN with) (NP (NNP Bear) (, ,) (NNP Stearns) (CC &) (NNP Co.)))) (, ,)) (VP (VBD said) (SBAR (IN that) (S (PP-TMP (IN over) (NP (DT the) (JJ past) (JJ few) (NNS years))) (NP-SBJ-1 (JJS most) (NN drug) (NNS makers)) (VP (VBP have) (VP (VP (VBN shed) (NP (PRP$ their) (JJ slow-growing) (NNS businesses))) (CC and) (VP (VBN instituted) (NP (NP (JJ other) (NN cost) (NNS savings)) (, ,) (PP (JJ such) (IN as) (S-NOM (NP-SBJ (-NONE- *-1)) (VP (VBG consolidating) (NP (NP (NN manufacturing) (NNS plants)) (CC and) (NP (JJ administrative) (NNS staffs))))))))))))) (. .)))
( (S (S-TPC-1 (PP-PRP (IN As) (NP (DT a) (NN result))) (, ,) (`` ``) (NP-SBJ (JJ major) (JJ new) (NNS products)) (VP (VBP are) (VP (VBG having) (NP (JJ significant) (NN impact)) (, ,) (PP-CLR (ADVP (RB even)) (IN on) (NP (NP (DT a) (NN company)) (PP (IN with) (NP (ADJP (RB very) (JJ large)) (NNS revenues)))))))) (, ,) ('' '') (NP-SBJ (NNP Mr.) (NNP Riccardo)) (VP (VBD said) (SBAR (-NONE- 0) (S (-NONE- *T*-1)))) (. .)))
( (S (NP-SBJ (NNS Analysts)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ-1 (NP (NN profit)) (PP (IN for) (NP (NP (DT the) (QP (NN dozen) (CC or) (RB so)) (JJ big) (NN drug) (NNS makers)) (, ,) (PP (IN as) (NP (DT a) (NN group))) (, ,)))) (VP (VBZ is) (VP (VBN estimated) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB have) (VP (VBN climbed) (NP-EXT (QP (IN between) (CD 11) (NN %) (CC and) (CD 14) (NN %)) (-NONE- *U*))))))))))) (. .)))
( (S (SBAR-ADV (IN While) (S (NP-SBJ (DT that)) (VP (VBZ 's) (RB not) (ADJP-PRD (JJ spectacular))))) (, ,) (NP-SBJ (NP (NNP Neil) (NNP Sweig)) (, ,) (NP (NP (DT an) (NN analyst)) (PP (IN with) (NP (NNP Prudential) (NNP Bache)))) (, ,)) (VP (VBD said) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN rate)) (PP (IN of) (NP (NN growth)))) (VP (MD will) (`` ``) (VP (VB look) (ADJP-PRD (RB especially) (JJ good) (SBAR (IN as) (S (NP-SBJ-1 (-NONE- *)) (VP (VBN compared) (NP (-NONE- *-1)) (PP-CLR (TO to) (NP (JJ other) (NNS companies))))))) (SBAR-ADV (IN if) (S (NP-SBJ (DT the) (NN economy)) (VP (VBZ turns) (ADVP-DIR (RB downward)))))))))) (. .) ('' '')))
( (S (NP-SBJ (NNP Mr.) (NNP Sweig)) (VP (VBD estimated) (SBAR (IN that) (S (NP-SBJ-1 (NP (NP (NNP Merck) (POS 's)) (NN profit)) (PP (IN for) (NP (DT the) (NN quarter)))) (VP (VBD rose) (PP-EXT (IN by) (NP (QP (RB about) (CD 22)) (NN %))) (, ,) (S-ADV (NP-SBJ-2 (-NONE- *-1)) (VP (VBN propelled) (NP (-NONE- *-2)) (PP (IN by) (NP-LGS (NP (NNS sales)) (PP (IN of) (NP (NP (PRP$ its) (NN line-up)) (PP (IN of) (NP (NP (JJ fast-growing) (NN prescription) (NNS drugs)) (, ,) (PP (VBG including) (NP (NP (NP (PRP$ its) (JJ anti-cholesterol) (NN drug)) (, ,) (NP (NNP Mevacor))) (: ;) (NP (NP (DT a) (JJ high) (NN blood) (NN pressure) (NN medicine)) (, ,) (NP (NNP Vasotec))) (: ;) (NP (NP (NNP Primaxin)) (, ,) (NP (DT an) (NN antibiotic))) (, ,) (CC and) (NP (NP (NNP Pepcid)) (, ,) (NP (DT an) (JJ anti-ulcer) (NN medication))))))))))))))))) (. .)))
( (S (S-TPC-2 (NP-SBJ (NN Profit)) (VP (VBD climbed) (SBAR-ADV (RB even) (IN though) (S (NP-SBJ-1 (NP (NNP Merck) (POS 's)) (NNS sales)) (VP (VBD were) (VP (VBN reduced) (NP (-NONE- *-1)) (PP-EXT (IN by) (`` ``) (NP (QP (CD one) (TO to) (CD three)) (NN percentage) (NNS points)) ('' '')) (PP-PRP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (DT the) (JJ strong) (NN dollar))))))))))) (, ,) (NP-SBJ (NNP Mr.) (NNP Sweig)) (VP (VBD said) (SBAR (-NONE- 0) (S (-NONE- *T*-2)))) (. .)))
( (S (PP-TMP (IN In) (NP (NP (DT the) (JJ third) (NN quarter)) (PP (IN of) (NP (CD 1988))))) (, ,) (NP-SBJ (NNP Merck)) (VP (VBD earned) (NP (NP (QP ($ $) (CD 311.8) (CD million)) (-NONE- *U*)) (, ,) (CC or) (NP (NP (CD 79) (NNS cents)) (NP-ADV (DT a) (NN share))))) (. .)))
( (S (PP-LOC (IN In) (NP (NP (NNP Rahway)) (, ,) (NP (NNP N.J.)) (, ,))) (NP-SBJ (DT a) (NNP Merck) (NN spokesman)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (DT the) (NN company)) (VP (VBZ does) (RB n't) (VP (VB make) (NP (NN earnings) (NNS projections))))))) (. .)))
( (S (NP-SBJ (NNP Mr.) (NNP Sweig)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (PRP he)) (VP (VBD estimated) (SBAR (IN that) (S (NP-SBJ (NP (NP (NNP Lilly) (POS 's)) (NNS earnings)) (PP (IN for) (NP (DT the) (NN quarter)))) (VP (VBD jumped) (NP-EXT (RB about) (CD 20) (NN %)) (, ,) (PP-PRP (ADVP (RB largely)) (IN because) (IN of) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (PRP$ its) (JJ new) (NN anti-depressant) (NNP Prozac)))))))))))) (. .)))
( (S (NP-SBJ-1 (NP (DT The) (NN drug)) (, ,) (VP (VBD introduced) (NP (-NONE- *)) (NP-TMP (JJ last) (NN year))) (, ,)) (VP (VBZ is) (VP (VBN expected) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB generate) (NP (NP (NNS sales)) (PP (IN of) (NP (QP (RB about) ($ $) (CD 300) (CD million)) (-NONE- *U*)))) (NP-TMP (DT this) (NN year))))))) (. .)))
( (S (`` ``) (S-TPC-1 (NP-SBJ-2 (PRP It)) (VP (VBZ 's) (VP (VBG turning) (PRT (RP out)) (S (NP-SBJ (-NONE- *-2)) (VP (TO to) (VP (VB be) (NP-PRD (DT a) (JJ real) (NN blockbuster)))))))) (, ,) ('' '') (NP-SBJ (NNP Mr.) (NNP Sweig)) (VP (VBD said) (S (-NONE- *T*-1))) (. .)))
( (S (PP-TMP (IN In) (NP (NP (JJ last) (NN year) (POS 's)) (JJ third) (NN quarter))) (, ,) (NP-SBJ (NNP Lilly)) (VP (VBD earned) (NP (NP (QP ($ $) (CD 171.4) (CD million)) (-NONE- *U*)) (, ,) (CC or) (NP (NP ($ $) (CD 1.20) (-NONE- *U*)) (NP-ADV (DT a) (NN share))))) (. .)))
( (S (PP-LOC (IN In) (NP (NNP Indianapolis))) (, ,) (NP-SBJ (NNP Lilly)) (VP (VBD declined) (NP (NN comment))) (. .)))
( (S (NP-SBJ (JJ Several) (NNS analysts)) (VP (VBD said) (SBAR (-NONE- 0) (S (NP-SBJ (PRP they)) (VP (VBD expected) (S (NP-SBJ (NP (NNP Warner-Lambert) (POS 's)) (NN profit)) (ADVP (RB also)) (VP (TO to) (VP (VB increase) (PP-EXT (IN by) (NP (QP (JJR more) (IN than) (CD 20)) (NN %))) (PP-DIR (IN from) (NP (NP (NP (QP ($ $) (CD 87.7) (CD million)) (-NONE- *U*)) (, ,) (CC or) (NP (NP ($ $) (CD 1.25) (-NONE- *U*)) (NP-ADV (DT a) (NN share))) (, ,)) (SBAR (WHNP-2 (-NONE- 0)) (S (NP-SBJ (PRP it)) (VP (VBD reported) (NP (-NONE- *T*-2)) (PP-TMP (IN in) (NP (NP (DT the) (JJ like) (NN period)) (NP-TMP (JJ last) (NN year)))))))))))))))) (. .)))
( (S (NP-SBJ-1 (DT The) (NN company)) (VP (VBZ is) (VP (VBN praised) (NP (-NONE- *-1)) (PP (IN by) (NP-LGS (NNS analysts))) (PP-PRP (IN for) (S-NOM (NP-SBJ (-NONE- *-1)) (VP (VP (ADVP-MNR (RB sharply)) (VBG lowering) (NP (PRP$ its) (NNS costs)) (PP-TMP (IN in) (NP (JJ recent) (NNS years)))) (CC and) (VP (VBG shedding) (NP (NP (JJ numerous) (NNS companies)) (PP (IN with) (NP (JJ low) (NN profit) (NNS margins)))))))))) (. .)))
( (S-1 (NP-SBJ (NP (DT The) (NN company) (POS 's)) (JJ lean) (NN operation)) (PRN (, ,) (S (NP-SBJ (NNS analysts)) (VP (VBD said) (SBAR (-NONE- 0) (S (-NONE- *T*-1))))) (, ,)) (VP (VBD allowed) (S (NP-SBJ (NP (JJ sharp-rising) (NNS sales)) (PP (IN from) (NP (NP (PRP$ its) (NN cholesterol) (NN drug)) (, ,) (NP (NNP Lopid)) (, ,)))) (VP (TO to) (VP (VB power) (NP (NNS earnings) (NN growth)))))) (. .)))
